Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H L Pahl

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Blood|January 15, 1995
The CD11b promoter directs high-level expression of reporter genes in macrophages in transgenic miceS Dziennis, R A Van Etten, H L Pahl, et al.
Oncogenesis|February 10, 2015
Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivoJ M Gajer, S D Furdas, A Gründer, et al.
Cell|September 6, 1996
Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alphaV Imbert, R A Rupec, A Livolsi, et al.
The Journal of Experimental Medicine|April 1, 1996
The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaBH L Pahl, B Krauss, K Schulze-Osthoff, et al.
Oncogene|November 12, 2013
Increased leukocyte survival and accelerated onset of lymphoma in the absence of MCL-1 S159-phosphorylationS E Lindner, M Wissler, A Gründer, et al.
The Journal of Cell Biology|December 1, 1996
Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivoD Schadendorf, M A Kern, M Artuc, et al.
Leukemia|August 4, 2012
Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitorsF U Wöhrle, S Halbach, K Aumann, et al.
Leukemia|February 9, 2016
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or bothS Koschmieder, T I Mughal, H C Hasselbalch, et al.
Leukemia|July 18, 2013
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) studyJ V Jovanovic, A Ivey, A M Vannucchi, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Blood|January 15, 1995
The CD11b promoter directs high-level expression of reporter genes in macrophages in transgenic miceS Dziennis, R A Van Etten, H L Pahl, et al.
Oncogenesis|February 10, 2015
Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivoJ M Gajer, S D Furdas, A Gründer, et al.
Cell|September 6, 1996
Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alphaV Imbert, R A Rupec, A Livolsi, et al.
The Journal of Experimental Medicine|April 1, 1996
The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaBH L Pahl, B Krauss, K Schulze-Osthoff, et al.
Oncogene|November 12, 2013
Increased leukocyte survival and accelerated onset of lymphoma in the absence of MCL-1 S159-phosphorylationS E Lindner, M Wissler, A Gründer, et al.
The Journal of Cell Biology|December 1, 1996
Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivoD Schadendorf, M A Kern, M Artuc, et al.
Leukemia|August 4, 2012
Gab2 signaling in chronic myeloid leukemia cells confers resistance to multiple Bcr-Abl inhibitorsF U Wöhrle, S Halbach, K Aumann, et al.
Leukemia|February 9, 2016
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or bothS Koschmieder, T I Mughal, H C Hasselbalch, et al.
Leukemia|July 18, 2013
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) studyJ V Jovanovic, A Ivey, A M Vannucchi, et al.
Pageof 5